The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status

Mikael Johansson, Anaïs Oudin, Katja Tiemann, Amandine Bernard, Anna Golebiewska, Olivier Keunen, Fred Fack, Daniel Stieber, Baofeng Wang, Håkan Hedman, Simone P. Niclou*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science